GABAergic involvement in motor effects of an adenosine A(2A) receptor agonist in mice

Neuropharmacology

Volumn 39, Issue 6, 2000, Pages 1004-1015

  Khisti, R T ^a   Chopde, C T ^a   Abraham, Elessy ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

A(2A) receptors; Adenosine; Amphetamine; Catalepsy; CGS 21680; D2 receptors; Dopamine; GABA; Motor hyperactivity; NECA

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; AMPHETAMINE; BACLOFEN; BICUCULLINE; DOPAMINE; DOPAMINE 2 RECEPTOR; MUSCIMOL; PHACLOFEN;

ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG EFFECT; GABAERGIC SYSTEM; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); AMPHETAMINE; ANIMALS; CATALEPSY; DOPAMINE AGENTS; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HYPERKINESIS; MALE; MICE; MOTOR ACTIVITY; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC P1;

EID: 0034056424     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00187-2     Document Type: Article

References (50)

1. Asin K.E., Bednarz L.M. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes. Neuroscience Letters. 113:1990;286-291.
2. Barraco R.A., Martens K.A., Parizon M., Normile H.J. Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat. Neuroscience Letters. 48:1984;139-144.
3. Barraco R.A., Martens K.A., Parizon M., Normile H.J. Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression. Brain Research Bulletin. 31:1993;397-404.
4. Brockwell N.T., Beninger R.J. The differential role A1 and A2 adenosine receptor subtypes in locomotor activity and place conditioning in rats. Behav. Pharmacol. 7:1996;373-383.
5. 3H]acetylcholine release from different areas of rat hippocampus. Journal of Neurochemistry. 63:1994;207-214.
6. Ferre S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology. 133:1997;107-120.
7. Ferre S., Guix T., Salles J., Cuffi L., Badia A., Casas M. Is experimental catalepsy properly measured? Pharmacol. Biochem. Behav. 35:1990;753-757.
8. Ferre S., Herrera-Marschitz M., Gabrowska-Anden M., Ungerstedt U., Casas M., Anden N.E. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behavior in short-term reserpinized mice. European Journal of Pharmacology. 192:1991;30-35.
9. Ferre S., Rubio A., Fuxe K. Stimulation of adenosine A2 receptors induces catalepsy. Neuroscience Letters. 130:1991;162-164.
10. Ferre S., Fuxe K., von Euler G., Johansson B., Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 5:1992;501-512.
11. Ferre S., O'Connor W.T., Fuxe K., Ungerstedt U. The striopallidal neuron: A main locus for adenosine-dopamine interactions in the brain. Journal of Neuroscience. 13:1993;5402-5406.
12. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience. 63:1994;765-773.
13. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends in Neurosciences. 20:1997;482-487.
14. Fink J.S., Weaver D.R., Rivekees S.A., Peterfreund R.A., Pollack A., Adler E.M., Reppert S.M. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in the rat striatum. Molecular Brain Research. 14:1992;186-195.
15. Florio C., Rosati A.M., Traversa U., Vertua R. Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity. Life Sciences. 60:1997;1477-1486.
16. Fredholm B.B., Abbrachio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
17. A receptor antagonists on extracellular dopamine levels. Brain Research. 599:1992;51-56.
18. Haley J.T., McCormick W.S. Pharmacological effects produced by intracerebral injections of drugs in conscious mouse. British Journal of Pharmacology. 12:1957;12-15.
19. Hauber W., Koch M. Adenosine A2a receptors in the nucleus accumbens modulate prepulse inhibition of the startle response. Neuroreport. 8:1997;1515-1518.
20. 2 receptors in the rat brain. Brain Research. 484:1989;111-118.
21. Kafka S.H., Corbett R. Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. European Journal of Pharmacology. 295:1996;147-154.
22. Kanda T., Shiozaki S., Shimada J., Suzuki F., Nakamura J. KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. European Journal of Pharmacology. 256:1994;263-268.
23. Kasture S.B., Mandhane S.N., Chopde C.T. Baclofen-induced catatonia: Modification by serotonergic agents. Neuropharmacology. 35:1996;595-598.
24. Lalonde R., Botez M.I. Subsensitivity to muscimol-induced catalepsy after long-term administration of phenytoin in rats. Psychopharmacology. 86:1985;77-80.
25. 2 adenosine receptors: Their presence and neuromodulatory role in the Central Nervous System. Gen. Pharmacol. 27:1996;925-933.
26. Malec D., Langwinski R. The influence of GABAergic system on cataleptogenic action of analgesics and haloperidol. Pol. J. Pharmacol. Pharm. 38:1986;501-507.
27. Mandhane S.N., Ghosh A.K., Chopde C.T. Adenosine A2 receptors modulate haloperidol-induce catalepsy in rats. European Journal of Pharmacology. 328:1997;135-141.
28. Mandhane, S.N., Khisti, R.T., Chopde, C.T., 1999. Adenosinergic modulation of 3α-hydroxy-5α-pregnan-20-one induced catalepsy in mice. Psychopharmacology (In press).
29. Martin G.E., Rossi D.J., Jarvis M.F. Adenosine agonists reduce conditioned avoidance responding in the rat. Pharmacology, Biochemistry and Behavior. 45:1993;951-958.
30. Martinez-Mir M.I., Probst A., Palacios J.M. Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease. Neuroscience. 42:1991;697-706.
31. Mayfield R.D., Suzuki F., Zahniser N.R. Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of globus pallidus. Journal of Neurochemistry. 60:1993;2334-2337.
32. Mayfield R., Larson G., Orona R.A., Zahniser N.R. Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a/D2 receptor interaction in globus pallidus. Synapse. 22:1996;132-138.
33. Mehta A.K., Ticku M.K. Baclofen induces catatonia in rats. Neuropharmacology. 26:1987;1419-1429.
34. Morelli M., Fenu S., Pinna A., Di Chiara G. Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lessioned rats. European Journal of Pharmacology. 251:1994;21-25.
35. Morelli M., Pinna A., Wardas J., Di Chiara G. Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience. 67:1995;49-55.
36. Mori A., Shindou T., Ichimura M., Nonaka H., Kase H. The role adenosine A2A receptors in regulating GABAergic synaptic transmission in striatal transmission in striatal medium spiny neurons. Journal of Neuroscience. 16:1996;605-611.
37. Mukhopadhyay S., Poddar M.K. Caffeine-induced locomotor activity: possible involvement of GABAergic-dopaminergic-adenosinergic interaction. Neurochem. Res. 20:1995;39-44.
38. Ogren S.O., Fuxe K. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neuroscience Letters. 85:1988;333-338.
39. Ogren S.O. The behavioural pharmacology of typical and atypical antipsychotic drugs. Csernasky J.G. Handbook of experimental pharmacology (antipsychotics, vol. 120). 1996;225-265 Springer, Berlin.
40. Ongini E., Fredholm B.B. Pharmacology of adenosine A2A receptors. Trends in Pharmacological Science. 17:1996;364-372.
41. 2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neuroscience Letters. 138:1992;169-172.
42. Phillis J.W. Inhibitory action of CGS 21680 on cerebral cortical neurones is antagonized by bicuculline and picrotoxin-is GABA involved? Brain Research. 807:1998;193-198.
43. Pinna A., di Chiara G., Wardas J., Morelli M. Blockade of A2a adenosine receptors positively modulates turning behaviour and c-fos expression induced by D1 agonists in dopamine-denervated rats. Eur. J. Neurosci. 8:1996;1176-1181.
44. Richardson P.J., Kase H., Jenner P.G. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends in Pharmacological Sciences. 18:1997;338-344.
45. 2A agonists: A potential new type of atypical antipsychotics. Neuropsychopharmacology. 17:1997;82-91.
46. 2A receptor agonist on dopamine receptor agonist-induced behavioural responses in rats. European Journal of Pharmacology. 347:1998;153-158.
47. Santiago M., Westerink B.H.C. The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual probe microdialysis study in awake rats. European Journal of Pharmacology. 219:1992;175-181.
48. Sarah T.M., Pollack A.E., Schusheim L., Fink S. Effects of selective adenosine A1 and A2A agonists on amphetamine-induced locomotion and c-fos in striatum and nucleus accumbens. Brain Research. 707:1996;75-80.
49. Schiffmann S.N., Vanderhaeghen J.J. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. Journal of Neuroscience. 13:1993;1080-1087.
50. Svenningsson P., Hall H., Sedvall G., Fredholm B.B. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse. 27:1997;322-335.